Riju Ray

6PUBLICATIONS
17CO-AUTHORS
Respiratory diseasesPacific Peoples medicine and treatmentsEpidemiological methods
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 01, 2021
Time-to-first exacerbation, adherence, and medical costs among US patients receiving umeclidinium/vilanterol or tiotropium as initial maintenance therapy for chronic obstructive pulmonary disease: a retrospective cohort study.

David Slade, Riju Ray, Chad Moretz

|Apr 29, 2021
Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities.

Ravi Kalhan, David Slade, Riju Ray

|Mar 17, 2021
Hospital Admission and Readmission Among US Patients Receiving Umeclidinium/Vilanterol or Tiotropium as Initial Maintenance Therapy for Chronic Obstructive Pulmonary Disease.

David Slade, Riju Ray, Chad Moretz

|Nov 05, 2020
Symptom Burden and GOLD Classification in Medicare Advantage Patients with COPD Initiating Umeclidinium/Vilanterol or Fluticasone Propionate/Salmeterol Therapy.

Chad Moretz, Beth Hahn, John White

|Jun 29, 2018
Efficacy of Umeclidinium/Vilanterol in Elderly Patients with COPD: A Pooled Analysis of Randomized Controlled Trials.

Riju Ray, Lee Tombs, Michael J Asmus

|Feb 02, 2017
Clinical Features of Influenza and Acute Respiratory Illness in Older Adults at Least 50 Years of Age in an Outpatient Setting in the Republic of Korea: a Prospective, Observational, Cohort Study.

Woo Joo Kim, Jin Soo Lee, Chang Kyu Lee

Pageof 1

Frequent Collaborators

4 joint publications

Beth Hahn

3 joint publications

Mei Sheng Duh

3 joint publications

Chad Moretz

2 joint publications

Guillaume Germain